Personalized cancer vaccines: Targeting the cancer mutanome
Personalized cancer vaccines: Targeting the cancer mutanome
About this item
Full title
Personalized cancer vaccines: Targeting the cancer mutanome
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Vaccine, 2017-02, Vol.35 (7), p.1094-1100
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights • Next generation sequencing technologies can identify candidate neoantigens in different types of cancers. • Neoantigens can be recognized by the immune system. • Neoantigens can be successfully targeted by personalized vaccines.
Alternative Titles
Full title
Personalized cancer vaccines: Targeting the cancer mutanome
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5448976
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5448976
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2016.05.073
